Hunter syndrome

(redirected from Mucopolysaccharidosis ii)
Also found in: Dictionary, Thesaurus, Medical.
Related to Mucopolysaccharidosis ii: Mucopolysaccharidosis iii, Hunter disease

Hunter syndrome

[′hənt·ər ‚sin‚drōm]
(medicine)
An X-linked recessive disease in which a deficiency of the enzyme iduronate sulfatase leads to the accumulation of mucopolysaccharides in various body tissues, resulting in developmental abnormalities, skeletal deformations, mental retardation, and, in severe cases, early death. Also known as mucopolysaccharidosis II.
Mentioned in ?
References in periodicals archive ?
The report provides a snapshot of the global therapeutic landscape of Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )
This report provides comprehensive information on the therapeutic development for Mucopolysaccharidosis II (MPS II) (Hunter Syndrome), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
This report provides comprehensive information on the therapeutic development for Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical Trials Review, H1, 2014

Full browser ?